Literature DB >> 17961112

Comparative expression of human endogenous retrovirus-W genes in multiple sclerosis.

Joseph M Antony1, Yu Zhu, Maryam Izad, Kenneth G Warren, Mohammed Vodjgani, Francois Mallet, Christopher Power.   

Abstract

Human endogenous retroviruses (HERVs) have been associated with multiple sclerosis (MS) pathogenesis. Several related HERV-W sequences have been implicated in disease occurrence and progression; the MS retrovirus (MSRV) is one such element whose envelope protein has been recently demonstrated to be involved in innate immune pathogenesis. To distinguish MSRV from other HERV-W sequences we analyzed the relative abundance of individual HERV-W env sequences by employing a real-time PCR approach using specific oligonucleotide primers and tissue samples from MS and non-MS patients. Our analyses reveal that ERVWE1 env-encoding DNA and RNA exhibited increased detection (p < 0.05) and expression (p < 0.01) in the brains of MS patients. Similarly, ERVWE1 env transcripts were inducible in glial cells (p < 0.05), while comparable changes in MSRV abundance were not observed. These results indicate that individual HERVs might have distinct roles in MS pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17961112     DOI: 10.1089/aid.2006.0274

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  24 in total

Review 1.  HERVs in neuropathogenesis.

Authors:  Tove Christensen
Journal:  J Neuroimmune Pharmacol       Date:  2010-04-27       Impact factor: 4.147

2.  Human endogenous retroviral syncytin exerts inhibitory effect on invasive phenotype of B16F10 melanoma cells.

Authors:  Hongbo Mo; Dongyun Ouyang; Lihui Xu; Qi Gao; Xianhui He
Journal:  Chin J Cancer Res       Date:  2013-10       Impact factor: 5.087

3.  Comprehensive analysis of human endogenous retrovirus group HERV-W locus transcription in multiple sclerosis brain lesions by high-throughput amplicon sequencing.

Authors:  Katja Schmitt; Christin Richter; Christina Backes; Eckart Meese; Klemens Ruprecht; Jens Mayer
Journal:  J Virol       Date:  2013-10-09       Impact factor: 5.103

Review 4.  The multiple sclerosis-associated retrovirus and its HERV-W endogenous family: a biological interface between virology, genetics, and immunology in human physiology and disease.

Authors:  Antonina Dolei; Hervé Perron
Journal:  J Neurovirol       Date:  2008-11-26       Impact factor: 2.643

Review 5.  DNA Methylation: a New Player in Multiple Sclerosis.

Authors:  Xiang Li; Bing Xiao; Xing-Shu Chen
Journal:  Mol Neurobiol       Date:  2016-06-17       Impact factor: 5.590

6.  An N-terminally truncated envelope protein encoded by a human endogenous retrovirus W locus on chromosome Xq22.3.

Authors:  Christina Roebke; Silke Wahl; Georg Laufer; Christine Stadelmann; Marlies Sauter; Nikolaus Mueller-Lantzsch; Jens Mayer; Klemens Ruprecht
Journal:  Retrovirology       Date:  2010-08-24       Impact factor: 4.602

7.  Multiple sclerosis: are protective immune mechanisms compromised by a complex infectious background?

Authors:  Bernd Krone; John M Grange
Journal:  Autoimmune Dis       Date:  2010-12-20

8.  Age- and disease-dependent HERV-W envelope allelic variation in brain: association with neuroimmune gene expression.

Authors:  Rakesh K Bhat; Kristofor K Ellestad; B Matt Wheatley; Rene Warren; Robert A Holt; Christopher Power
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

9.  Analysis of transcribed human endogenous retrovirus W env loci clarifies the origin of multiple sclerosis-associated retrovirus env sequences.

Authors:  Georg Laufer; Jens Mayer; Benedikt F Mueller; Nikolaus Mueller-Lantzsch; Klemens Ruprecht
Journal:  Retrovirology       Date:  2009-04-15       Impact factor: 4.602

Review 10.  HSV-1 and Endogenous Retroviruses as Risk Factors in Demyelination.

Authors:  Raquel Bello-Morales; Sabina Andreu; Inés Ripa; José Antonio López-Guerrero
Journal:  Int J Mol Sci       Date:  2021-05-27       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.